Results 121 to 130 of about 698,293 (229)

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

open access: yesJournal of Clinical Investigation, 1995
N. Vu-dac   +6 more
semanticscholar   +1 more source

Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries.

open access: yesArchives of pathology & laboratory medicine, 1989
Apolipoprotein A-I and apolipoprotein A-II, the two major protein components of the high-density lipoproteins, were visualized in human arteries using an immunofluorescence technique. Apolipoprotein A-I and apolipoprotein A-II were codeposited into the intima and upper media of normal arteries of atherosclerotic patients.
P, Bedossa   +5 more
openaire   +1 more source

Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties: A New Mechanism Linking HDL Protein Composition and Antiatherogenic Potential

open access: yesCirculation Research, 2004
V. Ribas   +8 more
semanticscholar   +1 more source

Apolipoprotein A-II Is Inversely Associated With Risk of Future Coronary Artery Disease

open access: yesCirculation, 2007
R. Birjmohun   +9 more
semanticscholar   +1 more source

Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1993
Craig H. Warden   +9 more
semanticscholar   +1 more source

Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Despite substantial clinical benefit from immune checkpoint inhibitors (ICI), advanced melanoma remains challenging due to frequent treatment resistance. Resistance may be intrinsic (primary) or emerge over time (secondary). Biomarkers predicting distinct resistance phenotypes before therapy are lacking.
Julian Kött   +17 more
wiley   +1 more source

Hormone therapy (HT) in women with premature ovarian insufficiency or early menopause: Time to think of a new paradigm for healthy aging. A joint FIGO and IMS position paper

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Premature ovarian insufficiency (POI) and early menopause (EM) affect millions of women worldwide. Compared with normal menopause, they confer a longer duration of estrogen deficiency and are associated not only with a shorter lifespan, but with a reduced healthspan, owing to an increased risk of cardiovascular, skeletal, cognitive and ...
Chiara Benedetto   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy